MTNB - Matinas BioPharma Holdings, Inc.

NYSE American - NYSE American Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
Enterprise Value 3
Trailing P/E
Forward P/E 1
PEG Ratio (5 yr expected) 1
Price/Sales (ttm)
Price/Book (mrq)
Enterprise Value/Revenue 3
Enterprise Value/EBITDA 6

Trading Information

Stock Price History

Beta (3Y Monthly) 3.11
52-Week Change 3-17.26%
S&P500 52-Week Change 38.78%
52 Week High 31.5000
52 Week Low 30.5010
50-Day Moving Average 30.6656
200-Day Moving Average 30.8234

Share Statistics

Avg Vol (3 month) 3498.05k
Avg Vol (10 day) 3247.24k
Shares Outstanding 5162.41M
Float 137.61M
% Held by Insiders 110.40%
% Held by Institutions 113.41%
Shares Short (Sep 30, 2019) 45.13M
Short Ratio (Sep 30, 2019) 411.99
Short % of Float (Sep 30, 2019) 43.47%
Short % of Shares Outstanding (Sep 30, 2019) 43.16%
Shares Short (prior month Aug 30, 2019) 45.25M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019


Profit Margin 0.00%
Operating Margin (ttm)-17,530.69%

Management Effectiveness

Return on Assets (ttm)-30.63%
Return on Equity (ttm)-52.72%

Income Statement

Revenue (ttm)89.81k
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)-0.00%
Gross Profit (ttm)-6.67M
EBITDA -15.46M
Net Income Avi to Common (ttm)-15.07M
Diluted EPS (ttm)-0.1300
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)36.83M
Total Cash Per Share (mrq)0.23
Total Debt (mrq)4.46M
Total Debt/Equity (mrq)11.03
Current Ratio (mrq)10.81
Book Value Per Share (mrq)0.21

Cash Flow Statement

Operating Cash Flow (ttm)-10.38M
Levered Free Cash Flow (ttm)-5.38M